Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eastern Cooperative Oncology Group
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
UNC Lineberger Comprehensive Cancer Center
M.D. Anderson Cancer Center
Washington University School of Medicine
University of Alabama at Birmingham
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
National Cancer Institute (NCI)
UNICANCER
Hoffmann-La Roche
Blue Note Therapeutics
Celgene
Mayo Clinic
Amgen
AHS Cancer Control Alberta
University of Alabama at Birmingham
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
University of Chicago
Exelixis